Matches in Wikidata for { <http://www.wikidata.org/entity/Q66044267> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- Q66044267 description "clinical trial" @default.
- Q66044267 description "ensayu clínicu" @default.
- Q66044267 description "klinisch onderzoek" @default.
- Q66044267 description "клінічне випробування" @default.
- Q66044267 name "R±CEOP90 Versus R±CEOP75 in Newly Diagnosed Young Patients With Medium/High-risk DLBCL" @default.
- Q66044267 name "R±CEOP90 Versus R±CEOP75 in Newly Diagnosed Young Patients With Medium/High-risk DLBCL" @default.
- Q66044267 type Item @default.
- Q66044267 label "R±CEOP90 Versus R±CEOP75 in Newly Diagnosed Young Patients With Medium/High-risk DLBCL" @default.
- Q66044267 label "R±CEOP90 Versus R±CEOP75 in Newly Diagnosed Young Patients With Medium/High-risk DLBCL" @default.
- Q66044267 prefLabel "R±CEOP90 Versus R±CEOP75 in Newly Diagnosed Young Patients With Medium/High-risk DLBCL" @default.
- Q66044267 prefLabel "R±CEOP90 Versus R±CEOP75 in Newly Diagnosed Young Patients With Medium/High-risk DLBCL" @default.
- Q66044267 P1050 Q66044267-433B3EEC-FB5F-42C1-9D18-D6FD4F8D7883 @default.
- Q66044267 P1132 Q66044267-F3C88521-0997-4FEE-8563-1787459D8498 @default.
- Q66044267 P1476 Q66044267-F10830B2-0013-4C42-A44E-34D4CD140901 @default.
- Q66044267 P2899 Q66044267-56A79649-7341-4E8C-A440-0CD92549FC3C @default.
- Q66044267 P3098 Q66044267-AFE395F9-651D-4AE7-B872-4BAC4D24C9C6 @default.
- Q66044267 P31 Q66044267-461C19E2-AE62-4FEC-8856-1352C1B2082B @default.
- Q66044267 P4135 Q66044267-ED411C01-4E9A-4239-A404-7DAAB9DABF5C @default.
- Q66044267 P4844 Q66044267-1FE5E9EB-740D-44DC-95C4-117FF425AF7F @default.
- Q66044267 P4844 Q66044267-2EDF032E-E6B5-4E19-A754-9F670C75AF27 @default.
- Q66044267 P4844 Q66044267-7551635B-536C-4028-841C-1DAAF0DE8D7E @default.
- Q66044267 P4844 Q66044267-878C32EF-C4CB-4D4D-88F9-836804B91EFC @default.
- Q66044267 P4844 Q66044267-B435099A-444D-44D1-ADD1-2A3301CE1077 @default.
- Q66044267 P4844 Q66044267-B56162F9-0D47-4ADE-BB2E-2F4444143C9C @default.
- Q66044267 P4844 Q66044267-B6E9EB6E-1B7C-4433-975C-6946D879AE93 @default.
- Q66044267 P580 Q66044267-A697EE88-7958-41B0-9407-30E38D5A9FE6 @default.
- Q66044267 P582 Q66044267-CFB8095A-6800-41E6-A66C-9D29526DF11A @default.
- Q66044267 P6099 Q66044267-93BAA503-B095-443F-8F53-C61E46D15AE6 @default.
- Q66044267 P6153 Q66044267-8779817A-08F2-4847-9F83-794D522A2A78 @default.
- Q66044267 P6153 Q66044267-9320E3BA-F468-4938-9406-39F0442712AB @default.
- Q66044267 P6153 Q66044267-BE9025F6-9979-4A4E-9DBC-D5B54538ED09 @default.
- Q66044267 P6153 Q66044267-C6637611-0FE9-41C6-B953-57500B38ECD8 @default.
- Q66044267 P8363 Q66044267-B9935119-C5A1-48A2-963C-3E0ED822B027 @default.
- Q66044267 P1050 Q208414 @default.
- Q66044267 P1132 "+408" @default.
- Q66044267 P1476 "A Prospective, Open, Randomized Controlled, Multi-center Phase III Clinical Trial Comparing High-dose Epirubicin and Standard-dose Epirubicin in R±CEOP in Newly Diagnosed Young Patients With Medium/High-risk Diffuse Large B-cell Lymphoma" @default.
- Q66044267 P2899 "+18" @default.
- Q66044267 P3098 "NCT03151044" @default.
- Q66044267 P31 Q30612 @default.
- Q66044267 P4135 "+60" @default.
- Q66044267 P4844 Q11426176 @default.
- Q66044267 P4844 Q27108063 @default.
- Q66044267 P4844 Q27262132 @default.
- Q66044267 P4844 Q27266327 @default.
- Q66044267 P4844 Q408524 @default.
- Q66044267 P4844 Q412323 @default.
- Q66044267 P4844 Q417222 @default.
- Q66044267 P580 "2016-07-01T00:00:00Z" @default.
- Q66044267 P582 "2017-07-01T00:00:00Z" @default.
- Q66044267 P6099 Q42824827 @default.
- Q66044267 P6153 Q11060357 @default.
- Q66044267 P6153 Q11085959 @default.
- Q66044267 P6153 Q30260510 @default.
- Q66044267 P6153 Q30296241 @default.
- Q66044267 P8363 Q78089383 @default.